XML 35 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Pro Forma Information - Vitro Acquisition
 6 Months Ended
Jun. 30, 2016
Pro Forma Information – Vitro Acquisition  
Pro Forma Information – Vitro Acquisition

16.  Pro Forma Information – Vitro Acquisition

 

Had the Vitro Acquisition, described in Note 15 and the related financing described in Note 8, occurred at the beginning of the period, unaudited pro forma consolidated net sales, earnings from continuing operations and earnings from continuing operations per share of common stock (diluted) would have been as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2015

 

 

 

As

 

Acquisition

 

Financing

 

Pro Forma

 

 

    

Reported

    

Adjustments

    

Adjustments

    

As Adjusted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$
1,543

 

$
224

 

$

 

 

$
1,767

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings from continuing operations attributable to the Company

 

$
42

 

$
29

 

$
(17)

 

$
54

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share from continuing operations

 

 
0.26

 

 

 

 

 

 

 

$
0.33

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2015

 

 

As

 

Acquisition

 

Financing

 

Pro Forma

 

    

Reported

    

Adjustments

    

Adjustments

    

As Adjusted

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$
2,964

 

$
431

 

$

 

 

$
3,395

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings from continuing operations attributable to the Company

 

$
113

 

$
52

 

$
(34)

 

$
131

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share from continuing operations

 

$
0.69

 

 

 

 

 

 

 

$
0.81